Terms: = Lymphoma AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1
110 results:
1. Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma models.
Capolla S; Argenziano M; Bozzer S; D'Agaro T; Bittolo T; De Leo L; Not T; Busato D; Dal Bo M; Toffoli G; Cavalli R; Gattei V; Bomben R; Macor P
Front Immunol; 2023; 14():1200310. PubMed ID: 37359561
[TBL] [Abstract] [Full Text] [Related]
2. A rare case of primary gastric Hodgkin lymphoma in an adolescent with Nijmegen breakage syndrome.
Batiuk E; Bassett M; Hakar M; Lin HC; Hunter AK
BMC Pediatr; 2023 Apr; 23(1):189. PubMed ID: 37085783
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea.
Yun J; Song H; Kim SM; Kim S; Kwon SR; Lee YE; Jeong D; Park JH; Kwon S; Yun H; Lee DS
Hum Genomics; 2023 Feb; 17(1):13. PubMed ID: 36814285
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic and therapeutic approach to children with Nijmegen breakage syndrome in relation to development of lymphoid malignancies.
Filipiuk A; Kozakiewicz A; Kośmider K; Lejman M; Zawitkowska J
Ann Agric Environ Med; 2022 Jun; 29(2):207-214. PubMed ID: 35767752
[TBL] [Abstract] [Full Text] [Related]
5. Genomic characterization of lymphomas in patients with inborn errors of immunity.
Ye X; Maglione PJ; Wehr C; Li X; Wang Y; Abolhassani H; Deripapa E; Liu D; Borte S; Du L; Wan H; Plötner A; Giannoula Y; Ko HB; Hou Y; Zhu S; Grossman JK; Sander B; Grimbacher B; Hammarström L; Fedorova A; Rosenzweig SD; Shcherbina A; Wu K; Warnatz K; Cunningham-Rundles C; Pan-Hammarström Q
Blood Adv; 2022 Sep; 6(18):5403-5414. PubMed ID: 35687490
[TBL] [Abstract] [Full Text] [Related]
6. Association of DNA repair genes polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis.
Zehtab S; Sattarzadeh Bardsiri M; Mirzaee Khalilabadi R; Ehsan M; Fatemi A
BMC Res Notes; 2022 Feb; 15(1):46. PubMed ID: 35164849
[TBL] [Abstract] [Full Text] [Related]
7. Geographical Distribution, Incidence, Malignancies, and Outcome of 136 Eastern Slavic Patients With Nijmegen Breakage Syndrome and
Sharapova SO; Pashchenko OE; Bondarenko AV; Vakhlyarskaya SS; Prokofjeva T; Fedorova AS; Savchak I; Mareika Y; Valiev TT; Popa A; Tuzankina IA; Vlasova EV; Sakovich IS; Polyakova EA; Rumiantseva NV; Naumchik IV; Kulyova SA; Aleshkevich SN; Golovataya EI; Minakovskaya NV; Belevtsev MV; Latysheva EA; Latysheva TV; Beznoshchenko AG; Akopyan H; Makukh H; Kozlova O; Varabyou DS; Ballow M; Ong MS; Walter JE; Kondratenko IV; Kostyuchenko LV; Aleinikova OV
Front Immunol; 2020; 11():602482. PubMed ID: 33488600
[TBL] [Abstract] [Full Text] [Related]
8. [Ceritinib in the treatment of an adult patient with advanced neuroblastoma positive to the somatic activating mutation of ALK F1174L.].
Soto Parra HJ; Noto L; Aiello MM
Recenti Prog Med; 2020 Dec; 111(12):58e-62e. PubMed ID: 33362184
[TBL] [Abstract] [Full Text] [Related]
9. Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome.
Wolska-Kusnierz B; Pastorczak A; Fendler W; Wakulinska A; Dembowska-Baginska B; Heropolitanska-Pliszka E; Piątosa B; Pietrucha B; Kałwak K; Ussowicz M; Pieczonka A; Drabko K; Lejman M; Koltan S; Gozdzik J; Styczynski J; Fedorova A; Miakova N; Deripapa E; Kostyuchenko L; Krenova Z; Hlavackova E; Gennery AR; Sykora KW; Ghosh S; Albert MH; Balashov D; Eapen M; Svec P; Seidel MG; Kilic SS; Tomaszewska A; Wiesik-Szewczyk E; Kreins A; Greil J; Buechner J; Lund B; Gregorek H; Chrzanowska K; Mlynarski W
Clin Cancer Res; 2021 Jan; 27(2):575-584. PubMed ID: 33082212
[TBL] [Abstract] [Full Text] [Related]
10. Treosulfan-Based Conditioning Regimen in Haematopoietic Stem Cell Transplantation with TCRαβ/CD19 Depletion in Nijmegen Breakage Syndrome.
Laberko A; Sultanova E; Gutovskaya E; Radygina S; Deripapa E; Kantulaeva A; Trakhtman P; Brilliantova V; Starichkova J; Shcherbina A; Maschan M; Maschan A; Balashov D
J Clin Immunol; 2020 Aug; 40(6):861-871. PubMed ID: 32602054
[TBL] [Abstract] [Full Text] [Related]
11. Nijmegen breakage syndrome: case report and review of literature.
Hasbaoui BE; Elyajouri A; Abilkassem R; Agadr A
Pan Afr Med J; 2020; 35():85. PubMed ID: 32537088
[TBL] [Abstract] [Full Text] [Related]
12. Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential.
Ma L; Zhu M; Gai J; Li G; Chang Q; Qiao P; Cao L; Chen W; Zhang S; Wan Y
J Nanobiotechnology; 2020 Jan; 18(1):12. PubMed ID: 31931812
[TBL] [Abstract] [Full Text] [Related]
13. nbn-Mre11 interaction is required for tumor suppression and genomic integrity.
Kim JH; Penson AV; Taylor BS; Petrini JHJ
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15178-15183. PubMed ID: 31285322
[TBL] [Abstract] [Full Text] [Related]
14. Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in children.
de Smith AJ; Lavoie G; Walsh KM; Aujla S; Evans E; Hansen HM; Smirnov I; Kang AY; Zenker M; Ceremsak JJ; Stieglitz E; Muskens IS; Roberts W; McKean-Cowdin R; Metayer C; Roux PP; Wiemels JL
Genes Chromosomes Cancer; 2019 Oct; 58(10):723-730. PubMed ID: 31102422
[TBL] [Abstract] [Full Text] [Related]
15. Inhibition of SKP2 Activity Impaired ATM-Mediated DNA Repair and Enhanced Sensitivity of Cisplatin-Resistant Mantle Cell lymphoma Cells.
Yan W; Yang Y; Yang W
Cancer Biother Radiopharm; 2019 Sep; 34(7):451-458. PubMed ID: 31025879
[No Abstract] [Full Text] [Related]
16. Metabolomics of neonatal blood spots reveal distinct phenotypes of pediatric acute lymphoblastic leukemia and potential effects of early-life nutrition.
Petrick LM; Schiffman C; Edmands WMB; Yano Y; Perttula K; Whitehead T; Metayer C; Wheelock CE; Arora M; Grigoryan H; Carlsson H; Dudoit S; Rappaport SM
Cancer Lett; 2019 Jun; 452():71-78. PubMed ID: 30904619
[TBL] [Abstract] [Full Text] [Related]
17. Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.
Urtishak KA; Wang LS; Culjkovic-Kraljacic B; Davenport JW; Porazzi P; Vincent TL; Teachey DT; Tasian SK; Moore JS; Seif AE; Jin S; Barrett JS; Robinson BW; Chen IL; Harvey RC; Carroll MP; Carroll AJ; Heerema NA; Devidas M; Dreyer ZE; Hilden JM; Hunger SP; Willman CL; Borden KLB; Felix CA
Oncogene; 2019 Mar; 38(13):2241-2262. PubMed ID: 30478448
[TBL] [Abstract] [Full Text] [Related]
18. Discovery of 4-(((4-(5-chloro-2-(((1s,4s)-4-((2-methoxyethyl)amino)cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor.
Wang B; Wu J; Wu Y; Chen C; Zou F; Wang A; Wu H; Hu Z; Jiang Z; Liu Q; Wang W; Zhang Y; Liu F; Zhao M; Hu J; Huang T; Ge J; Wang L; Ren T; Wang Y; Liu J; Liu Q
Eur J Med Chem; 2018 Oct; 158():896-916. PubMed ID: 30253346
[TBL] [Abstract] [Full Text] [Related]
19. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.
Saito Â; Souza EE; Costa FC; Meirelles GV; Gonçalves KA; Santos MT; Bressan GC; McComb ME; Costello CE; Whelan SA; Kobarg J
J Proteome Res; 2017 Sep; 16(9):3147-3157. PubMed ID: 28695742
[TBL] [Abstract] [Full Text] [Related]
20. Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary Syndrome.
Kann BH; Park HS; Yeboa DN; Aneja S; Girardi M; Foss FM; Roberts KB; Wilson LD
Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):520-526.e2. PubMed ID: 28655598
[TBL] [Abstract] [Full Text] [Related]
[Next]
